Related references
Note: Only part of the references are listed.Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination
Junji Kawada et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
Kazuhiro Kakimi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients
Tomoki Makino et al.
SURGERY (2010)
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
Hisashi Wada et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Comparison of Time Trends in Stomach Cancer Incidence (1973-2002) in Asia, from Cancer Incidence in Five Continents, Vols IV-IX
K. Katanoda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Autoantibodies in breast cancer: their use as an aid to early diagnosis
C. Chapman et al.
ANNALS OF ONCOLOGY (2007)
Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site
Masaaki Motoori et al.
EUROPEAN JOURNAL OF CANCER (2006)
Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1
Oezlem Tuereci et al.
CANCER LETTERS (2006)
Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer
M Yamamoto et al.
ONCOLOGY (2004)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
P Uciechowski et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
